Correction to: Genetics in Medicine 2021; https://doi.org/10.1038/s41436-021-01172-3; published online 20 May 2021
In addition, on page 2 of the article (right column, fifth paragraph, third sentence), the phrase "deletions of" has been added. The correct sentence is given below. Other technical difficulties were noted for genes such as EPCAM associated with Lynch syndrome and GREM1-associated polyposis, where routine detection of common deletions or duplications could be difficult at this time by ES/GS in many laboratories. On page 7 of the article (right column, third paragraph, fifth sentence), the word “high” should be replaced by “low”. The correct sentence is given below. MODY3 does not require insulin treatment and responds well to low dose oral sulfonylureas, typically lower doses than are customary for most type 2 diabetics. On page 8 of the article (left column, third paragraph, second sentence), the word “SERPINC1” should be replaced by “SERPINA1”. The correct sentence is given below. The SFWG decided that including gene phenotypes such as HMBS-associated acute intermittent porphyria and SERPINA1/alpha-1-antitrypsin deficiency with interventions involving environmental exposures or behavior modification was beyond the scope of this list.
The original article has been corrected.
Author information
Authors and Affiliations
Consortia
Additional information
*The Board of Directors of the American College of Medical Genetics and Genomics approved this statement on 22 February 2021.
Supplementary information
Rights and permissions
About this article
Cite this article
Miller, D.T., Lee, K., Chung, W.K. et al. Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 23, 1582–1584 (2021). https://doi.org/10.1038/s41436-021-01278-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41436-021-01278-8
This article is cited by
-
A practical checklist for return of results from genomic research in the European context
European Journal of Human Genetics (2023)
-
Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: further evidence of validity
European Journal of Human Genetics (2022)
-
Voluntary workplace genomic testing: wellness benefit or Pandora’s box?
npj Genomic Medicine (2022)
-
A systematic literature review of disclosure practices and reported outcomes for medically actionable genomic secondary findings
Genetics in Medicine (2021)
-
Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications
Genetics in Medicine (2021)